Indravadan Patel

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5K citations · Full text

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman et al. · American Heart Journal · 2010 · 481 citations

Thrombosis, Cardiovascular Disease, Medicine +10

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald et al. · The Lancet · 2015 · 389 citations

Anti-factor Xa Activity, Edoxaban Dose, Clinical Epidemiology +6

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48

Deepak K. Gupta, Amil M. Shah, Robert P. Giugliano et al. · European Heart Journal · 2013 · 203 citations · Full text

Addendum of Newer Anticoagulants to the SIR Consensus Guideline

Indravadan Patel, Jon Davidson, Boris Nikolic et al. · Journal of Vascular and Interventional Radiology · 2013 · 118 citations · Full text

Thrombosis, Cardiovascular Disease, Medicine +7